<DOC>
	<DOCNO>NCT00171132</DOCNO>
	<brief_summary>The purpose study show valsartan compare atenolol favorable effect exercise capacity , quality life , diastolic function elevate blood pressure hypertensive postmenopausal overweight woman impair exercise tolerance despite normal leave ventricular ejection fraction ( LVEF ) .</brief_summary>
	<brief_title>VALENCE : Valsartan Versus Atenolol Exercise Capacity Hypertensive Overweight Postmenopausal Women</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Atenolol</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<criteria>Body mass index ( BMI ) must ≥ 27 &lt; 35 Symptoms impaired exercise capacity ( e.g . report shortness breath exertion question ) report Visit 1 patient history shortness breath improve diuretic therapy LV ejection fraction must &gt; 45 % measure echocardiography Visit 2 . Impaired exercise capacity measure VO2max Visit 4 : VO2max &gt; 14 &lt; 22 ml ⋅kg1 ⋅min1 Mean sit diastolic blood pressure ( MSDBP ) ≥ 110 mmHg and/or Mean sit systolic blood pressure ( MSSBP ) ≥ 180 mmHg LVEF ≤ 45 % Inability completely discontinue previous antihypertensive medication safely duration study Heavy smoker ( &gt; 20 cigarettes/day )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Postmenopausal</keyword>
	<keyword>woman</keyword>
	<keyword>overweight</keyword>
	<keyword>hypertension</keyword>
	<keyword>impaired</keyword>
	<keyword>exercise</keyword>
	<keyword>capacity</keyword>
	<keyword>valsartan</keyword>
	<keyword>atenolol</keyword>
	<keyword>hydrochlorothiazide</keyword>
</DOC>